An international clinical trial led by University College London and the London School of Hygiene & Tropical Medicine reported strong performance from an AI tool used for radiotherapy planning in cervical and prostate cancer. The study supports the use of algorithm-assisted planning to improve treatment delivery consistency, with implications for workflow standardization in settings where planning resources can be limited.